Authors/Disclosures
|
Alessandro Biffi, MD
(Eli Lilly and Company)
|
Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company. |
|
Dharampreet Singh, MD
(Mainline HealthCare Neurology)
|
No disclosure on file |
|
Gustavo A. Patino, MD, PhD
(Western Michigan University Homer Stryker MD School of Medicine)
|
Dr. Patino has nothing to disclose. |
|
Joji Kuramatsu, MD
(University Hospital Erlangen)
|
No disclosure on file |
|
Kelly L. Polito, MD
(Keck Medicine of USC)
|
No disclosure on file |
|
Audrey Leasure
|
Ms. Leasure has nothing to disclose. |
|
Hooman Kamel, MD
(Weill Cornell Medical College)
|
Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim. |
|
Christina Kourkoulis
|
No disclosure on file |
|
Darine Kassar, MD
|
Dr. Kassar has nothing to disclose. |
|
Kristin Schwab
|
No disclosure on file |
|
|
No disclosure on file |
|
Edip M. Gurol, MD
(Massachusetts General Hospital)
|
The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer. |
|
Steven M. Greenberg, MD, PhD, FAAN
|
Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care. |
|
Anand Viswanathan, MD
(Massachusetts General Hospital)
|
Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. |
|
Christopher D. Anderson, MD, PhD, FAAN
(Brigham and Women's Hospital)
|
The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care. |
|
Stefan Schwab, MD
(U. of Erlangen, Dept. of Neurology)
|
Dr. Schwab has nothing to disclose. |
|
Jonathan Rosand, MD
(Massachusetts General Hospital)
|
Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities. |
|
Daniel Woo, MD, FAAN
(University at Buffalo)
|
The institution of Dr. Woo has received research support from NIH. |
|
Hagen B. Huttner, MD, PhD
(University Hospital Giessen, Department of Neurology)
|
No disclosure on file |
|
Kevin N. Sheth, MD, FAAN
(Yale UniversityDivision of Neuro and Critical Care)
|
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |